5-alpha reductase inhibitors and prostate cancer mortality
Hamilton RJ, Chavarriaga J, Khurram N, Lau C, Luo J, Liu N, Komisarenko M, Kulkarni G, Wallis C, Juurlink DN, Fleshner N, Finelli A. JAMA Netw Open. 2024; 7(8):e2430223.
Hamilton RJ, Chavarriaga J, Khurram N, Lau C, Luo J, Liu N, Komisarenko M, Kulkarni G, Wallis C, Juurlink DN, Fleshner N, Finelli A. JAMA Netw Open. 2024; 7(8):e2430223.
Scime NV, Grandi SM, Ray JG, Dennis CL, De Vera MA, Banack HR, Vigod SN, Boblitz A, Brown HK. Int J Epidemiol. 2024; 53(5):dyae115.
Sankar A, Stukel TA, Baxter NN, Wijeysundera DN, Hwang SW, Wilton AS, Chan TCY, Sarhangian V, Simpson AN, de Mestral C, Pincus D, Campbell RJ, Urbach DR, Irish J, Gomez D. BJS Open. 2024; 8(4):zrae088.
Campbell RJ, El-Defrawy SR, Bell CM, Urbach DR, Paterson JM, Stukel TA, Gill SS, Irish J, Baxter NN, Gomez D. CMAJ. 2024; 196:E965-72.
Kendzerska T, Povitz M, Gershon AS, Ryan CM, Talarico R, Saymeh M, Robillard R, Ayas NT, Pendharkar SR. BMJ Open Respir Res. 2024; 11(1):e002476.
Qureshi D, Grubic N, Maxwell CJ, Bush SH, Casey G, Isenberg SR, Tanuseputro P, Webber C. J Am Med Dir Assoc. 2024; Aug 23 [Epub ahead of print].
Rahman B, Babe G, Griffith LE, Price D, Lapointe-Shaw L, Costa AP. PLoS One. 2024; 19(8):e0307611.
Robinson CH, Rickard M, Jeyakumar N, Smith G, Richter J, Van Mieghem T, Santos JD, Chanchlani R, Lorenzo AJ. J Am Soc Nephrol. 2024; Aug 21 [Epub ahead of print].
Bota SE, McArthur E, Naylor KL, Blake PG, Yau K, Hladunewich MA, Levin A, Oliver MJ. Kidney360. 2024; Aug 16. [Epub ahead of print].
Coltin H, Pequeno P, Liu N, Tsang DS, Gupta S, Taylor MD, Bouffet E, Ramaswamy V, Nathan PC. Pediatr Blood Cancer. 2024; Aug 16 [Epub ahead of print].